Occurrence of selected antibiotics and antiretroviral drugs in Nairobi River Basin, Kenya

Science of the Total Environment

Volumn 539, Issue , 2016, Pages 206-213

  Ngumba, Elijah ^a   Gachanja, Anthony ^b   Tuhkanen, Tuula ^a  

^a UNIVERSITY OF JYVÄSKYLÄ   (Finland)

^b JOMO KENYATTA UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Kenya)

Author keywords

Antibiotics; Antiretroviral; Measured environmental concentration; Occurrence; Predicted no effect concentration; Risk quotient

Indexed keywords

ANTIBIOTICS; DRUG PRODUCTS; EFFLUENT TREATMENT; EFFLUENTS; ELECTROSPRAY IONIZATION; EXTRACTION; IONIZATION OF LIQUIDS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PHASE SEPARATION; RISK ASSESSMENT; RIVERS; WASTEWATER TREATMENT; WATERSHEDS;

ANTIRETROVIRALS; ENVIRONMENTAL CONCENTRATION; OCCURRENCE; PREDICTED NO-EFFECT CONCENTRATIONS; RISK QUOTIENTS;

RIVER POLLUTION;

ANTIBIOTIC AGENT; ANTIRETROVIRUS AGENT; CIPROFLOXACIN; LAMIVUDINE; NEVIRAPINE; SULFAMETHOXAZOLE; TRIMETHOPRIM; ZIDOVUDINE; ANTIINFECTIVE AGENT; WATER POLLUTANT;

ANTIBIOTICS; CONCENTRATION (COMPOSITION); DRUG; EFFLUENT; RIVER WATER; SPECIES OCCURRENCE; WASTEWATER; WATER QUALITY;

ARTICLE; CONCENTRATION (PARAMETERS); EFFLUENT; ELECTROSPRAY MASS SPECTROMETRY; ENVIRONMENTAL MONITORING; KENYA; LIQUID CHROMATOGRAPHY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RIVER BASIN; SOLID PHASE EXTRACTION; WASTE WATER MANAGEMENT; WATER ANALYSIS; WATER CONTAMINATION; WATER SAMPLING; ANALYSIS; ANIMAL; CHEMISTRY; DAPHNIA; FISH; RISK ASSESSMENT; RIVER; WATER POLLUTANT;

KENYA; NAIROBI BASIN;

ALGAE; DAPHNIA;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-RETROVIRAL AGENTS; DAPHNIA; ENVIRONMENTAL MONITORING; FISHES; KENYA; RISK ASSESSMENT; RIVERS; SOLID PHASE EXTRACTION; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; WATER POLLUTANTS, CHEMICAL;

EID: 84941312804     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2015.08.139     Document Type: Article

References (68)

1. Abellán M.N., Giménez J., Esplugas S. Photocatalytic degradation of antibiotics: the case of sulfamethoxazole and trimethoprim. Catal. Today 2009.
2. Al-Ahmad A., Daschner F.D., Kümmerer K. Biodegradability of cefotiam, ciprofloxacin, meropenem, penicillin G, and sulfamethoxazole and inhibition of waste water bacteria. Arch. Environ. Contam. Toxicol. 1999, 37(2):158-163.
3. Andreozzi R., Marotta R., Paxéus N. Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment. Chemosphere 2003.
4. APHRC Population and Health Dynamics in Nairobi's Informal Settlements: Report of the Nairobi Cross-sectional Slums Survey (NCSS) 2000 2002, (Nairobi).
5. Al Aukidy M., Verlicchi P., Jelic A., Petrovic M., Barcelò D. Monitoring Release of Pharmaceutical Compounds: Occurrence and Environmental Risk Assessment of two WWTP Effluents and their Receiving Bodies in the Po Valley, Italy. Sci Total Environ. 2012, 438:15-25. Elsevier B.V., (Nov 1).
6. Aydin E., Talinli I. Analysis, Occurrence and Fate of Commonly used Pharmaceuticals and Hormones in the Buyukcekmece Watershed, Turkey. Chemosphere 2013, 90:2004-2012. Elsevier Ltd, (Feb).
7. Babić S., Horvat A.J.M.M., Mutavdžić Pavlović D., Kaštelan-Macan M. Determination of pKa values of active pharmaceutical ingredients. TrAC Trends Anal. Chem. 2007, 26(11):1043-1061. (Dec).
8. Backhaus T., Sumpter J., Blanck H. On Ecotoxicology of Pharmaceuticals Mixtures. Pharm Environ 2008, 257-276. Springer Berlin Heidelberg, Berlin, Heidelberg. K. Kümmerer (Ed.).
9. Besse J.-P., Kausch-Barreto C., Garric J. Exposure assessment of pharmaceuticals and their metabolites in the aquatic environment: application to the French situation and preliminary prioritization. Hum. Ecol. Risk. Assess. 2008, 14(4):665-695. (Jul 29).
10. Bueno M.J.M., Gomez M.J., Herrera S., Hernando M.D., Agüera A., Fernández-Alba A.R. Occurrence and persistence of organic emerging contaminants and priority pollutants in five sewage treatment plants of Spain: two years pilot survey monitoring. Environ Pollut 2012, 164:267-273. Elsevier Ltd, (May).
11. Caban M., Migowska N., Stepnowski P., Kwiatkowski M., Kumirska J. Matrix Effects and Recovery Calculations in Analyses of Pharmaceuticals Based on the Determination ofβ-Blockers andβ-agonists in Environmental Samples. J Chromatogr A [Internet] 2012, 1258:117-127. Elsevier B.V., (Available from: http://dx.doi.org/10.1016/j.chroma.2012.08.029).
12. Carballa M., Omil F., Lema J.M. Comparison of predicted and measured concentrations of selected pharmaceuticals, fragrances and hormones in Spanish sewage. Chemosphere 2008, 72(8):1118-1123. (Jul).
13. Charkhabi A., Sakizadeh M. Assessment of spatial variation of water quality parameters in the most polluted branch of the Anzali wetland, Northern Iran. Pol. J. Environ. Stud. 2006, 15(3):395-403.
14. X Van D., Dewulf J., Langenhove H.V., Demeestere K. Science of the Total Environment Fluoroquinolone Antibiotics: An Emerging Class of Environmental Micropollutants. Sci Total Environ 2014, 500-501C:250-269. Elsevier B.V., (Sep 13).
15. EMEA Guideline on the Environmental Risk Assessment of Medicinal Products for Human Use 2006, European Medicines Agency, London.
16. Erulkar A.S., Matheka J.K. Adolescence in the Kibera Slums of Nairobi Kenya [Internet] 2007, (Nairob; Available from: http://www.popcouncil.org/uploads/pdfs/AdolKiberaSlums.pdf).
17. Escher B.I., Baumgartner R., Koller M., Treyer K., Lienert J., McArdell C.S. Environmental Toxicology and Risk Assessment of Pharmaceuticals from Hospital Wastewater. Water Res 2011, 45:75-92. Elsevier Ltd, (Jan).
18. Gao L., Shi Y., Li W., Niu H., Liu J., Cai Y. Occurrence of Antibiotics in Eight Sewage Treatment Plants in Beijing, China. Chemosphere 2012, 86:665-671. Elsevier Ltd, (Feb).
19. Global Antibiotic Resistance Partnership-Kenya Working Group Situation Analysis and Recommendations: Antibiotic Use and Resistance in Kenya 2011, (Washington, DC and New Delhi).
20. Gracia-Lor E., Sancho J.V., Serrano R., Hernández F. Occurrence and Removal of Pharmaceuticals in Wastewater Treatment Plants at the Spanish Mediterranean Area of Valencia. Chemosphere 2012, 87:453-462. Elsevier Ltd, (Apr).
21. Gulkowska A., He Y., So M.K., LWY Y., Leung H.W., Giesy J.P., et al. The occurrence of selected antibiotics in Hong Kong coastal waters. Mar. Pollut. Bull. 2007, 54(8):1287-1293. (Aug).
22. Göbel A., Thomsen A., McArdell C.S., Joss A., Giger W. Occurrence and sorption behavior of sulfonamides, macrolides, and trimethoprim in activated sludge treatment. Environ. Sci. Technol. 2005, 39(11):3981-3989.
23. Heberer T. Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicol. Lett. [Internet] 2002, 131(1-2):5-17. (May 10, Available from: http://www.ncbi.nlm.nih.gov/pubmed/11988354).
24. Index Mundi Kenya Demographics Profile [Internet] 2013, ([cited 2015 Jan 6]. Available from: http://www.indexmundi.com/kenya/demographics_profile.html).
25. Jain S., Kumar P., Vyas R.K., Pandit P., Dalai A.K. Occurrence and removal of antiviral drugs in environment: a review. Water Air Soil Pollut. 2013.
26. Jekatierynczuk-Rudczyk E. Threats to a small river and its urban catchment: hydrological and hydrochemical assessment of Jaroszówka River in Białystok, Poland. Ecohydrol. Hydrobiol. 2009, 8(1):77-87. (Jan).
27. Jiang Y., Li M., Guo C., An D., Xu J., Zhang Y., et al. Distribution and ecological risk of antibiotics in a typical effluent-receiving river (Wangyang River) in north China. Chemosphere 2014, 112:267-274. (Oct).
28. Johnson M.A., Moore K.H.P., Yuen G.J., Bye A., Pakes G.E. Clinical pharmacokinetics of lamivudine. Clin. Pharmacokinet. 1999, 36(1):41-66.
29. K'oreje K.O., Demeestere K., De Wispelaere P., Vergeynst L., Dewulf J., Van Langenhove H. From multi-residue screening to target analysis of pharmaceuticals in water: development of a new approach based on magnetic sector mass spectrometry and application in the Nairobi River Basin, Kenya. Sci Total Environ 2012, 437:153-164. Elsevier B.V., (Oct 15).
30. Kasprzyk-Hordern B., Dinsdale R.M., Guwy A.J. The occurrence of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs in surface water in South Wales, UK. Water Res. 2008, 42(13):3498-3518. (Jul).
31. Kasprzyk-Hordern B, Dinsdale RM, Guwy AJ. The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters. Water Res. Elsevier Ltd; 2009 (Feb);43(2):363-80.
32. Keen O.S., Linden K.G. Degradation of antibiotic activity during UV/H2O2 advanced oxidation and photolysis in wastewater effluent. Environ. Sci. Technol. 2013.
33. Kim S.D., Cho J., Kim I.S., Vanderford B.J., Snyder S.A. Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters. Water Res. 2007, 41(5):1013-1021. (Mar).
34. Kosma C.I., Lambropoulou D.A., Albanis T.A. Investigation of PPCPs in wastewater treatment plants in Greece: occurrence, removal and environmental risk assessment. Sci Total Environ 2014, 466-467:421-438. Elsevier B.V., (Jan 1).
35. Kümmerer K., Henninger A. Promoting resistance by the emission of antibiotics from hospitals and households into effluent. Clin. Microbiol. Infect. 2003, 9(12):1203-1214.
36. Leung H.W., Jin L., Wei S., Tsui M.M.P., Zhou B., Jiao L., et al. Pharmaceuticals in tap water: human health risk assessment and proposed monitoring framework in China. Environ. Health Perspect. 2013, 121(7):839-846. (Jul).
37. López-Doval J.C., De Castro-Català N., Andrés-Doménech I., Blasco J., Ginebreda A., Muñoz I. Analysis of monitoring programmes and their suitability for ecotoxicological risk assessment in four Spanish basins. Sci Total Environ 2012, 440:194-203. Elsevier B.V., (Dec 1).
38. Martinez J.L. Environmental pollution by antibiotics and by antibiotic resistance determinants. Environ Pollut 2009, 157:2893-2902. Elsevier Ltd, (Nov).
39. McArdell C.S., Molnar E., Suter M.J.F., Giger W. Occurrence and fate of macrolide antibiotics in wastewater treatment plants and in the Glatt Valley Watershed, Switzerland. Environ. Sci. Technol. 2003, 37(24):5479-5486. (Dec 15).
40. Muñoz I., Gómez-Ramos M.J., Agüera A., Fernández-Alba A.R., García-Reyes J.F., Molina-Díaz A. Chemical evaluation of contaminants in wastewater effluents and the environmental risk of reusing effluents in agriculture. TrAC Trends Anal. Chem. 2009, 28(6):676-694. (Jun).
41. NACC Kenya HIV Estimates 2014, (Nairobi).
42. Nairobi City Water and Sewerage Company Wastewater Treatment Process [Internet] 2015, ([cited 2015 Jun 1]. Available from: http://www.nairobiwater.co.ke/waste-water-treatment.html).
43. NASCOP-Kenya Guidelines for Antiretroviral Therapy in Kenya [Internet] 2011, 230. Ministry of Medical Services, Republic of Kenya, Nairobi, (Available from: www.nascop.or.ke).
44. National Council for Population and Development Kenya Population Situation Analysis [Internet] 2013, (Nairobi; Available from: http://countryoffice.unfpa.org/kenya/drive/FINALPSAREPORT.pdf).
45. Pereira A.M.P.T., Silva L.J.G., Meisel L.M., Lino C.M., Pena A. Environmental impact of pharmaceuticals from Portuguese wastewaters: geographical and seasonal occurrence, removal and risk assessment. Environ Res 2015, 136:108-119. Elsevier, (Jan).
46. Prasse C., Schlüsener M.P., Schulz R., Ternes T.A. Antiviral drugs in wastewater and surface waters: a new pharmaceutical class of environmental relevance?. Environ. Sci. Technol. 2010, 44(5):1728-1735. (Mar 1).
47. Radjenović J., Petrović M., Barceló D. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the Conventional Activated Sludge (CAS) and Advanced Membrane Bioreactor (MBR) treatment. Water Res 2009, 43:831-841. Elsevier Ltd, (Feb).
48. Radke M., Lauwigi C., Heinkele G., Múrdter T.E., Letzel M. Fate of the antibiotic sulfamethoxazole and its two major human metabolites in a water sediment test. Environ. Sci. Technol. 2009, 43(9):3135-3141.
49. Richardson S.D., Ternes T.A. Water Analysis: Emerging Contaminants and Current Issues. Anal Chem 2014, 86:2813-2848. American Chemical Society, (Mar).
50. Riska P., Lamson M., Macgregor T., Sabo J., Hattox S., Pav J., et al. Disposition and biotransformation of the antiretroviral drug nevirapine in humans. Drug Metab. Dispos. 1999, 27(8):895-901.
51. Santos J.L., Aparicio I., Alonso E. Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants. A case study: Seville city (Spain). Environ. Int. 2007, 33(4):596-601. (May).
52. Shimadzu TOC User's Manual 2012, TOC-LCPH/CPN.
53. Singlas E., Pioger J.C., Taburet M., Colaneri S., Fillastre J.P. Comparative pharmacokinetics of zidovudine (AZT) and its metabolite (G.AZT) in healthy subjects and HIV seropositive patients. Eur. J. Clin. Pharmacol. 1989, 36(6):639-640.
54. Straub JO. Aquatic environmental risk assessment for human use of the old antibiotic sulfamethoxazole in Europe. Environ. Toxicol. Chem. [Internet]. 2015;9999(9999):1-13. (Available from: ). http://doi.wiley.com/10.1002/etc.2945.
55. Sui Q., Huang J., Deng S., Yu G., Fan Q. Occurrence and Removal of Pharmaceuticals, Caffeine and DEET in Wastewater Treatment Plants of Beijing, China. Water Res 2010, 44:417-426. Elsevier Ltd, (Jan).
56. Tewari S., Jindal R., Kho Y.L., Eo S., Choi K. Major pharmaceutical residues in wastewater treatment plants and receiving waters in Bangkok, Thailand, and associated ecological risks. Chemosphere 2013, 91(5):697-704. (Apr).
57. UmandeTrust, COHRE, Hakijamii The Right to Water and Sanitation in Kibera, Nairobi, Kenya [Internet] 2007, (Nairobi; Available from: http://www.hakijamii.com/publications/waterightkibera.pdf).
58. USEPA, SRC Scientific Databases SRC [Internet] 2012, ([cited 2014 Apr 20]. Available from: http://www.srcinc.com/what-we-do/environmental/tools-and-models.html#episuite).
59. Wagenlehner F.M.E., Kinzig-Schippers M., Sörgel F., Weidner W., Naber K.G. Concentrations in plasma, urinary excretion and bactericidal activity of levofloxacin (500mg) versus ciprofloxacin (500mg) in healthy volunteers receiving a single oral dose. Int. J. Antimicrob. Agents 2006, 28(6):551-559.
60. Wang H., Wang T., Zhang B., Li F., Toure B., Omosa I.B., et al. Water and wastewater treatment in Africa - current practices and challenges. Clean: Soil, Air, Water 2014, 42(8):1029-1035.
61. Watkinson A.J., Murby E.J., Kolpin D.W., Costanzo S.D. The Occurrence of Antibiotics in an Urban Watershed: From Wastewater to Drinking Water. Sci Total Environ 2009, 407:2711-2723. Elsevier B.V., (Apr 1).
62. Watts G. Something in the water. BMJ 2011, 343:48-52. (Jan).
63. WHO Consolidated Guidelines on the use of Antiretroviral Drugs for Treating and Preventing HIV Infection 2013, 94-95. WHO, Geneva, (109,32-3,90,146-53).
64. Vieno N.M., Tuhkanen T., Kronberg L. Analysis of neutral and basic pharmaceuticals in sewage treatment plants and in recipient rivers using solid phase extraction and liquid chromatography-tandem mass spectrometry detection. J. Chromatogr. A 2006, 1134(1-2):101-111. (Nov 17).
65. Voloshenko-Rossin A., Gasser G., Cohen K., Gun J., Cumbal-Flores L., Parra-Morales W., et al. Emerging pollutants in the Esmeraldas watershed in Ecuador: discharge and attenuation of emerging organic pollutants along the San Pedro-Guayllabamba-Esmeraldas rivers. Environ Sci Process Impacts [Internet] 2015, 17:41-53. Royal Society of Chemistry, (Available from: http://xlink.rsc.org/?DOI=C4EM00394B).
66. Xu W., Zhang G., Li X., Zou S., Li P., Hu Z., et al. Occurrence and elimination of antibiotics at four sewage treatment plants in the Pearl River Delta (PRD), South China. Water Res. 2007, 41(19):4526-4534. (Nov).
67. Zhang R., Zhang G., Zheng Q., Tang J., Chen Y., Xu W., et al. Occurrence and risks of antibiotics in the Laizhou Bay, China: Impacts of River Discharge. Ecotoxicol Environ Saf 2012, 80:208-215. Elsevier, (Jun).
68. Zuccato E., Castiglioni S., Bagnati R., Melis M., Fanelli R. Source, Occurrence and Fate of Antibiotics in the Italian Aquatic Environment. J Hazard Mater 2010, 179:1042-1048. Elsevier B.V., (Jul 15).